ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000732.1|Capsular_1 # 2 # 103 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.422	BGC0000732.1|Capsular_1 	2	103	+	Loose	1000	20.0162	msbA	40.91	3003950	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	AAGGAAGTTGTGTGTATTCTTTTAGGTGACAGTGAATTTAAGAATTTGGCGGGCAGATGCCCGGGCAGTATCCGTGTATTATCAGTTCCAATGGATTTGTGA	KEVVCILLGDSEFKNLAGRCPGSIRVLSVPMDL	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ	5.67	gnl|BL_ORD_ID|2185|hsp_num:0	2423			993	1059	metronidazole
BGC0000732.1|Capsular_2 # 194 # 493 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.567	BGC0000732.1|Capsular_2 	194	493	-	Loose	450	24.2534	AAC(3)-IIIa	25.35	3002536	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	GTGGCCCAGACCCAGCGGCTGTGCCTGGCGCACGTTCATGATGGTTACGCCCGGCGGGCAAATGGCCTGGACTTCCGCCAGCAGCTGGCGCTTCACGCGCTGCTCAAGCAGGGCTTCCAGCTCGTAGGAGGTATCAAAGTGGTTTTCCACTGCATTCTTCGAGGAGTGCGTCACCAGGACAATCTCTTTGATCCCGGCGGCGACGATTTCGTCAACAATGTACTGAATCATTGGCTTATCAACGATCGGCAGCATCTCCTTTGGAATTGCCTTTGTGGCCGGCAGCATATGCATGCCTAG	MAQTQRLCLAHVHDGYARRANGLDFRQQLALHALLKQGFQLVGGIKVVFHCILRGVRHQDNLFDPGGDDFVNNVLNHWLINDRQHLLWNCLCGRQHMHA	MTDLNIPHTHAHLVDAFQALGIRAGQALMLHASVKAVGAVMGGPNVILQALMDALTPDGTLMMYAGWQDIPDFIDSLPDALKAVYLEQHPPFDPATARAVRENSVLAEFLRTWPCVHRSANPEASMVAVGRQAALLTANHALDYGYGVESPLAKLVAIEGYVLMLGAPLDTITLLHHAEYLAKMRHKNVVRYPCPILRDGRKVWVTVEDYDTGDPHDDYSFEQIARDYVAQGGGTRGKVGDADAYLFAAQDLTRFAVQWLESRFGDSASYG	36.53	gnl|BL_ORD_ID|1736|hsp_num:0	1879			30	237	neomycin; dibekacin; sisomicin; kanamycin A; tobramycin; paromomycin; lividomycin; 5-episisomicin; gentamicin
BGC0000732.1|Capsular_3 # 536 # 1048 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.581	BGC0000732.1|Capsular_3 	536	1048	+	Loose	300	26.1794	dfrA3	25.64	3003105	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	GTGGTGGTGCTGCCGGATATCATTCTCGATGGCGGCACTGCGGACCCGCTGCGCTATAACCTCGCTGCCATGGTCGCCCGTTTTAACGAGACCGGCCGCAGCCAGGTGCTGGCGAAACGCATGCCGGGGGATCTCTCCGAATACTCCGTTATCCAGACCAAAGAGCCAATGGTGGCCGAAGGGCAGGTGGCGCGTATCGTTGAGTTCATTGAAAAACCGGACGAACCGCAGACCCTGGACTCCGACCTGATGGCGGTGGGCCGCTACGTGCTGTCGGCAGATATCTGGGCTGAACTTGAACGAACCCAGCCGGGCGCCTGGGGCCGTATCCAGCTAACCGACGCCATTGCCGAACTGGCGAAGAAGCAGTCCGTTGACGCGATGCTGATGACCGGCGAAAGCTATGACTGCGGTAAAAAAATGGGCTACATGCAGGCCTTCGTCACCTACGGGATGCGTAACCTGAAAGAAGGTACCAAATTCCGCGAAAGCATTAAAAAATTGCTGGCCTGA	MVVLPDIILDGGTADPLRYNLAAMVARFNETGRSQVLAKRMPGDLSEYSVIQTKEPMVAEGQVARIVEFIEKPDEPQTLDSDLMAVGRYVLSADIWAELERTQPGAWGRIQLTDAIAELAKKQSVDAMLMTGESYDCGKKMGYMQAFVTYGMRNLKEGTKFRESIKKLLA	MLISLIAALAHNNLIGKDNLIPWHLPADLRHFKAVTLGKPVVMGRRTFESIGRPLPGRRNVVVSRNPQWQAEGVEVAPSLDAALALLTDCEEAMIIGGGQLYAEALPRADRLYLTYIDAQLNGDTHFPDYLSLGWQELERSTHPADDKNSYACEFVTLSRQR	104.94	gnl|BL_ORD_ID|470|hsp_num:0	511			9	126	trimethoprim
BGC0000732.1|Capsular_4 # 1135 # 1389 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.431	BGC0000732.1|Capsular_4 	1135	1389	-	Loose	700	28.1054	PDC-113	50.0	3006491	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	ATGTCTGTACCAGCTCGCATGCCAATTCATTTCACATTTTTATGCATGCAAGTGAGATGTTTAAAGCGGAAACATGATCGCAGTCAAGTTTTATTTTTGGCTGACGTTGACCGCTTTCCCTGCGCTTTAGGAATTGTCGCACTAAGTGACTATTCACAAAGCATTATTGCCGCTACTCCGACCATTGCACCACAGAGGCCAGAGACAAACTACCAGAAGTCTCCGAAGCCATACGTTTCTTTACAATCGTTATAA	MSVPARMPIHFTFLCMQVRCLKRKHDRSQVLFLADVDRFPCALGIVALSDYSQSIIAATPTIAPQRPETNYQKSPKPYVSLQSL	MRDTRFPCLCGIAASTLLFATTPTIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRRYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR	21.16	gnl|BL_ORD_ID|4181|hsp_num:0	5251			12	90	
BGC0000732.1|Capsular_5 # 1460 # 1666 # -1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.589	BGC0000732.1|Capsular_5 	1460	1666	-	Loose	400	21.9422	kamB	32.26	3004102	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (A1408)	GTGGCCGCTGAAGCCGGTGTAATCCAGCTCGCGAATACCCAGACCCCAGCCCATAAAGGCCAGTTTGGAGGCGCAGACGATGGCGCCGGTGATGCCGAACAGCAAACTCCACTGCCACGCCAGCAACCGCGACGTTTTACGCAGTATCAGGACAATAAACAGCGCCGCTGCGCTGGGCAGCAAAACGGTGCTATCGCCAAAAAATGA	MAAEAGVIQLANTQTPAHKGQFGGADDGAGDAEQQTPLPRQQPRRFTQYQDNKQRRCAGQQNGAIAKK	MRRVVGKRVQEFSDAEFEQLRSQYDDVVLDVGTGDGKHPYKVARQNPSRLVVALDADKSRMEKISAKAAAKPAKGGLPNLLYLWATAERLPPLSGVGELHVLMPWGSLLRGVLGSSPEMLRGMAAVCRPGASFLVALNLHAWRPSVPEVGEHPEPTPDSADEWLAPRYAEAGWKLADCRYLEPEEVAGLETSWTRRLHSSRDRFDVLALTGTISP	31.63	gnl|BL_ORD_ID|2390|hsp_num:0	2770			87	180	neomycin; apramycin; kanamycin A
BGC0000732.1|Capsular_6 # 1775 # 2071 # 1 # ID=1_6;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.572	BGC0000732.1|Capsular_6 	1775	2071	+	Loose	700	23.8682	MOX-7	33.33	3002189	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	MOX beta-lactamase	GTGGTGGGTTATTCACGGCTGGTCATCCATGTGCATTCCGTCTCGGAAGTGATCGCTGGCCTGCTGCTCGGTGCTGCTGGCAGCGCTTTGTTCCTGCTGCTGCAAAAACGTACCACCCCTTCGGAAAGCGTAAGTATTTCGTGGGGCGGCGTCGTGTGCATGGTGATGGTCCCGCTTATCCTGTTGCATAGCGGCAGTAAAGCGCCGACTCAATCCCTGCTGGGGCAAATTGCCACCGCAGTAGGGCCGTTGGATAAACCCTTTACGCGTACCGAGCTGCATAAGCAGGCCTGGTAA	MVGYSRLVIHVHSVSEVIAGLLLGAAGSALFLLLQKRTTPSESVSISWGGVVCMVMVPLILLHSGSKAPTQSLLGQIATAVGPLDKPFTRTELHKQAW	MQQRQSILWGALATLMWAGLVHAGDKAATDPLRPVVDASIRPLLKEHRIPGMAVAVLKDGKAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGSFELDDKASLFAPWLKGSVFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYANPSIGLFGYLAASSMKQPFDRLMEQTMLPGLGLYHTYLTVPEQAMGHYAYGYSKEDKPIRVTPGMLADEAYGIKTSSADLLRFVKANIGGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYAYPVSEQTLLAGNSPAMIYNAIPAVPAPAAAGHPVLFNKTGSTNGFGAYVAFVPAKGIGIVMLANRNSPIEARIKAAHAILTQLAR	25.59	gnl|BL_ORD_ID|1507|hsp_num:0	1637			15	135	
BGC0000732.1|Capsular_7 # 3383 # 3727 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.597	BGC0000732.1|Capsular_7 	3383	3727	-	Loose	1000	27.335	HelR	45.45	3007208	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target protection	helicase-like RNA polymerase protection protein	ATGAGGGATTACTGCGTACTGATTCATCTGACTGGCAGAAATCTGATACTGCCATGGGCCCACCCAGCGCAGCCACCATATTTCTGGCGCCGCCTGCTCTGCCCGCTGCATCAGAAAGCCGGTCATCGGCCGCATAGCATCCCCGCGGATCAGGCTACCTTCATACCCAGGCCCCCACCACTGCGGTACCTGGCCAAAGGAGAGCCACTGATTCCAGAACTTCACCGCACCGTAGGCGCCGTTGGCGTTGAAACGCGATCCGTTGCTGATCCGCTCTCCCCCTTCGACGTTGCCCTGGAGGTGGACATCCCACCACTCGCCGCTGTTGTTAAACGCCAGGCCTAA	MRDYCVLIHLTGRNLILPWAHPAQPPYFWRRLLCPLHQKAGHRPHSIPADQATFIPRPPPLRYLAKGEPLIPELHRTVGAVGVETRSVADPLSPFDVALEVDIPPLAAVVKRQA	MRVLSSVDQLDGTSAFDLPDRLSAKTDPALIAADERHFSAIAKSLAETITELSDRLDATRKAPGGVGREAMDRDAEIHRLTGRLRTLRRFGLDLCLGRIVTADDAEPVYVGRLGLTDSTGRRLLVDWRSPAAEPFFAATHADPMGLTSRRRYRWTGGRVSDYWDEVFTADGLEEHAALDDQSAFIASLGSSRSPQMRDVLATIQADQDAIIRAGSRGTLVVDGGPGTGKTVVALHRSAHLLYADPRLGHRRGGVLFVGPHQPYLAYVADVLPSLGEEGVRTCTVRDLVAEGAGAAVERDAEVARLKSSADMVRAIEAAVRFYEEPPTQRMTVSTDWADVRLTADDWAEAFDAPEAGTPHNEAREQIWEELGSILLGKLGDEVPEEEFRRALRQDEELAGALHGAWPLLEAADLVGDLWSVPAYLRKCAPWLDREDVAKLQRADAQAWTVSDLPLLDAARQRLGDPEAARRRRRQQATVAAERARMADVIADVLAADDDGEGAVTMLRGQDLKDTLVDEAALTGVEPDLLAGPFAHIVVDEAQELSDAEWQMLLLRCPSRSFTIVGDRAQARHGFTESWEERLARVGLDRITVASLSINYRTPEEVMAEAEPAIRAALPDANVPTSVRSSGVPVLRGPVEELDTIVDEWLAANADGTACVIGAPRFRPGPRVRSLTPSLSKGLEFDLVVLVDPEDFGGGIEGAVDRYVAMTRATKQLVILTSS	15.79	gnl|BL_ORD_ID|4837|hsp_num:0	5819			342	408	rifampin; rifaximin; rifabutin
BGC0000732.1|Capsular_8 # 3905 # 4468 # 1 # ID=1_8;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.433	BGC0000732.1|Capsular_8 	3905	4468	+	Loose	450	25.409	aadA13	25.0	3002613	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	TTGGCTGGATTCGACTTTAAGTATAAGCTTGAACCTACTCTCGGTTGGCCAATTAGTTTTTACGGTCAATTGATTGGTGAGGATGAGGCTGGATTTTTACCCTCCGCTAATATGTACCTCGGTGGTATAGAAGGGCATCATGGATGGGGAAAAGATGCGATAAATTGGTATTTAGAAGCCCATGATACGAGAACAAACATGAGTAGAACCGGATATAGCTATTGGCATCATCTTTATACAGATGGCTATTATCAACAAGGCTACTCTCTTGGTGATGCGATGGGAGGAGATGGGCAATTATTCGCTGGCAAGATCGAGCTTATAACAGAGGATAACCAACGCTGGAGTTCACGTCTGGTTTACGCCAAAGTAAATCCTGAGAGTCAGTCGATAAACAAGGCATTCCCTCATGCTGATACATTAAAAGGAATTCAACTGGGGTGGAGTGGAGATGTTTACCGGTCTGTTCGTATAAATACTTCGCTTTGGTATACCAACGCTAACAACAGCGATAGTGATGACGTTGGAGCCAGCGCAGGGATAGAGATACCGTTTAGTTTATAA	MAGFDFKYKLEPTLGWPISFYGQLIGEDEAGFLPSANMYLGGIEGHHGWGKDAINWYLEAHDTRTNMSRTGYSYWHHLYTDGYYQQGYSLGDAMGGDGQLFAGKIELITEDNQRWSSRLVYAKVNPESQSINKAFPHADTLKGIQLGWSGDVYRSVRINTSLWYTNANNSDSDDVGASAGIEIPFSL	MRDSVTAEISTQLSKVLSVIEHHLEPTLLAVHLYGSAVDGGLKPYSDIDLLVTVTARLDDTTRRALFNDLLEVSAFPGESEILRAIEVTIVVHEDIMPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLIKALNETLKLWNSQPDWAGDERNVVLTLSRIWYSAATGKIAPKDVAANWAMEHLPAQHQSVLLEARQAYLGQEEDRSVLRADKLEEFIHFMKSEITKVLGNDV	70.57	gnl|BL_ORD_ID|1908|hsp_num:0	2087			426	642	spectinomycin; streptomycin
BGC0000732.1|Capsular_9 # 4614 # 5747 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.414	BGC0000732.1|Capsular_9 	4614	5747	+	Loose	600	29.6462	EstT	35.9	3007459	protein homolog model	n/a	n/a	macrolide antibiotic; glycylcycline; tetracycline antibiotic	antibiotic inactivation	macrolide esterase	ATGAAGAAAAAAATTGTTAGATTTTCGGCATTAGCATTGGCAATTGGGTTTCTAACAGGTTGTACTATTGTTCCAGGCCAAGGGTTAAATAGTCTACGTAAGAATGTTGTTGAACTCCCCGACAGCGACTACGATCTCGATAAGTTGGTAAATGTTTATCCCATGACGCCAGGCCTAATAGACCAGCTTCGTCCGGCAACCGTTCTTGCTCGCCCAAATCCGCAGTTGGATAATTTACTACGTAGTTATGAATATCGTATTGGTGTAGGTGATGTACTGATGGTTACTGTATGGGACCATCCGGAATTAACTACTCCTGCTGGCCAGTATAGGAGTGCAAGTGATACCGGGAATTGGGTAAATTCAGATGGCACAATATTTTATCCTTACATCGGAAAGATACTTGTAGCCGGGAAAACTCTTAGTCAAGTACGCCAGGATATAGCAAATCGTCTTACTACTTATATTGAGAGTCCTCAAGTCGATGTTAGCATAGCTGCTTTTAGATCACAAAAGACCTATGTCACAGGTGAAGTAATTAAATCAGGACAGCAGCCAATTACAAATATTCCGCTTACGGTTATGGATGCAATAAACGCTGCAGGTGGACTTGCACCTGATGCAGACTGGCGTAACGTTGTTTTAACCCATAATGGGAAGGATACAAAGATCTCATTATATGCATTAATGCAAAAGGGTGATTTGTCACAGAATCATCTCCTTTATCCTGGTGATATTCTTTTTGTTCCCCGTAATGATGACCTGAAAGTATTTGTCATGGGCGAAGTTGGTAAGCAAAGCACTCTTAAGATGGATCGAAGTGGTATGACTTTAGCTGAGGCCATTGGGAATGCGGAAGGTATTTCTCAGGAATTTAGTGATGCAACGGGTGTCTTTGTCGTTCGGCAACTGAAAGAGGATAAACAAGGCAAGATAGCAAATGTTTACCAACTAAATGCTCAAGATGCTTCAGCGATGGTACTGAGCACTGAATTTCAGTTACAACCTTATGATATCGTTTATGTAACTACTGCCCCATTGGTTCGATGGAATCGGGTTATATCACAGTTGGTGCCCACAATTACTGGTGTACATGATATGACTGAGACAGGTAAATATATTCGAACTTGGTGA	MKKKIVRFSALALAIGFLTGCTIVPGQGLNSLRKNVVELPDSDYDLDKLVNVYPMTPGLIDQLRPATVLARPNPQLDNLLRSYEYRIGVGDVLMVTVWDHPELTTPAGQYRSASDTGNWVNSDGTIFYPYIGKILVAGKTLSQVRQDIANRLTTYIESPQVDVSIAAFRSQKTYVTGEVIKSGQQPITNIPLTVMDAINAAGGLAPDADWRNVVLTHNGKDTKISLYALMQKGDLSQNHLLYPGDILFVPRNDDLKVFVMGEVGKQSTLKMDRSGMTLAEAIGNAEGISQEFSDATGVFVVRQLKEDKQGKIANVYQLNAQDASAMVLSTEFQLQPYDIVYVTTAPLVRWNRVISQLVPTITGVHDMTETGKYIRTW	MKKKLLWILILGLIIISCKQRKTEMKEKIIKTNGIELCTESFGNKKNPAILLVAGATVSMLYWDTEFCQQLSEKGFFVIRYDNRDVGKSTNYEPGSTPYDIVDLTNDAISILDGYKIDKAHFVGISLGGLISQIASIKFADRVNSLTLMSSGPWGDSDPTIPEMDTSILDFHSKAGTVNWTNEDSVVNYLIQGAELMSGKKQFDKQRSEKLIRAEFNRANNYISMFNHAASQGGGGEEYWNRLNEIKQPTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGHELHVDDWKSIIDGIEKHIND	123.20	gnl|BL_ORD_ID|4956|hsp_num:0	5948			483	600	tigecycline
BGC0000732.1|Capsular_10 # 5900 # 6187 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.330	BGC0000732.1|Capsular_10 	5900	6187	+	Loose	1100	28.1054	salA	35.48	3003749	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	sal-type ABC-F protein	ATGAGAATTGCCAAATCTTTTGATGTTTCTTTGGATGGACATAAAGGTAAACAATTTAGCGCAAAGTTAGGAAGGGAGTATGATCTTATCTTGGTGATGGAAAGAGCCCATATTACACAAATTAGTAGTATTGCACCTGAAGTTAGAGGTAAAACTATGTTGTTGAATCATTGGGTTAATCAAAAGGATATTCCTGATCCTTACCGAAAAAGTGATGAAGCTTTCGAATCAGTTTTTAATTTGATCGAAAAAGCATGCTTTAAATGGGTTGAAAAATTAAATGGATAA	MRIAKSFDVSLDGHKGKQFSAKLGREYDLILVMERAHITQISSIAPEVRGKTMLLNHWVNQKDIPDPYRKSDEAFESVFNLIEKACFKWVEKLNG	MLFLFEEKALEVEHKVLIPELTFSIEDHEHLAIVGVNGVGKSTLLKVIHQDQSVDSAMMEQDLTPYYDWTVMDYIIESYPEIAKIRLQLNHTDMINKYIELDGYIIEGEIVTEAKKLGIKEEQLEQKISTLSGGEQTKVSFLKVKMSKASLLLIDEPTNHMDLEMKEWLTKAFKQEQRAILFVSHDRTFLNETPDAILELSLDGAKKYIGKYDKYKQQKDIEHETLKLQYEKQQKEQAAIEETIKKYKAWYQKAEQSASVRSPYQQKQLSKLAKRFKSKEQQLNRKLDQEHIPNPHKKEKTFSIQHHNFKSHYLVQFNHVSFAYDNRKIFDDVSFYIKRNQNVIVEGRNGTGKSTLIKLILGELEPTKGDITVHPELEIGYFSQDFENLNMHHTVLDEILEIPEMKEADARTILASFYFDKDRINDVVETLSMGEKCRLQFVKLYFSNPHIMILDEPTNYFDIGMQENIIQLIQSFQGSVLIVSHDNYFKSQIKDQTWTIKNHQMTHENVQVKDPINTESMKHHLKELEQYTDERNRETEF	17.56	gnl|BL_ORD_ID|2051|hsp_num:0	2265			801	894	lincomycin; clindamycin; virginiamycin M1; tiamulin; retapamulin
BGC0000732.1|Capsular_11 # 6206 # 8356 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.352	BGC0000732.1|Capsular_11 	6206	8356	+	Loose	500	27.335	mphA	29.17	3000316	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGTCTTCTACGAAATCTAATAAACCACTCAGCGCAGATGAAATTGACATTGGTCGTCTGTATGGTGAATTAATTGACCATCGTAAATTGATTCTAAGTATTACTGCAATTTCTGTATTTATAAGCATTTTATATTGTCTGTTTGCTACTCCGATTTATCAAGCTGATGCTTTAATTCAAGTTGAACAAAAGCAAGGTAATACAATACTTGAGAGTTTGAGTCAGGTTCTTCCAGATGCACAACCTCAATCAGCACCTGAAATATCATTGCTTCAGTCAAGAATGGTATTAGGTAAAACAGTAGACGATCTTAAATTACAGACTATAGTAACAAATAATTATTTTCCTATTGTTGGTAAAGGCTGGGCTAGATTATTTGGCGATAATCCCGGTAATATTTATGTTGAGAATATGGTTATACCCGAGAAAAAGCTTAATGAGAATAAGAAAGCAATAGTAACTGTCATTAATGATAGCGAATATACTGTATCTATTGACGATTCTACTTATCATGGTAAGGTCGGTGTTCAAATAAAAGAGCCAAATATATCATTGTTAATAAATAAAATTGATGCTCAACCTGGTGAAAGTTTCAAGATTAAATATAAGACTAGATTAGAGGCAATAAATGATTTAGCGAATTCTTTTCATGTTGAAGATCAAGGAAAAGATACTGGCATGTTAGCCTTAACTTTGATTGGAGATGACCCATCATTAATTTCAGTGATACTCAATAAAATAAGCGAAAACTATTTGGAGCAAAATGTCTCTAGGCAAGCTGCACAAGATGCAAGGAGTCTCGAGTTTCTAAATGAACGCTTGCCAAAAGTAAGAGATGATCTGGATAGAGCAGAAGATAAGCTCAATAGTTATAGAAAACAGAAAGATTCGGTCGATTTGTCATTAGAAGCTAAAGCTACATTAGATCAACTAGTTAATGTTGATAATCAAATTAATGAACTGACCTTTCGAGAGGCTGAAATATCGCAGCTTTTTACTAAGGATCATCCGACTTATAAAGCACTTATCGAGAAGAAAAATACATTAAGTAAAGAGCGTGGTTTGTTGAATAATAGAATTTCTGCGATGCCAGCAACTCAGCAAGAAGTCTTACGTCTGAGTCGTGATGTCGAATCTGGACGTACTGTTTATATGATGCTATTAAACAGACAGCAGGAGCTGGAAATTTCTAAATCAAGTGCAATTGGTAATGTTCGTATTGTTGATGAGTCCGTTACTGAGCCAGAGCCAGTAAAACCCAAAAAGGCAATGGTTATTATATTAGGAGTTCTTCTCGGTGGCTTAATCTCTGTTGGTGTCGTTTTACTAAGAGTATCATTTAGAAGAGGAATTGAATCGCCCGAACAGCTTGAAGAAGTAGGGATTAGCGTTTATTCAAGCATTCCTGTATCAGAATGGTTAGAAAGTAATAAAAAAACAAGGCATGGTGATAGCAGAAATCTGCTTGCTATAGATAATCCAGCTGACTTAGCCATAGAGGCGATTAGGGGCTTAAGAACAAGCCTCCATTTTGCTATGCTTGAAGCCAAAAATAATATATTAATGATATCGGGTGCTAGCCCTAATGCTGGTAAAACATTTGTTAGCAGTAATTTGGCAGTAATTGAAGCTCAAACCGGTAAGTCTGTATTATTTATTGATGCCGATATGAGAAAGGGGTACTCTCATAAATTATTTGGCATAAACATTGGCAATGATAATGTTGGATTGTCGGAATTGCTTTCAAGTAATTATGATTTTGAAAAAGCAATTAATAAGATAGCAGAAATGAAAATAGACTTCATTTCTAGAGGTCAAGTACCACATAATCCGGCTGAAATGTTAACAAGCATGAAATTTGATAATTTATTACGATGGGCCGCAAGCAATTATGACTTGGTTATTGTTGATACACCGCCAGTCCTAGCAGTGACAGATGCTGAGATTATTGGTCGCTATGTTGGAACAACTTTGTTGGTTGCTCGATATGAAACAAACACGGTTAAAGAAATGGAAGTCAGTATAAAGCGTTTTGAGCGAAGCGGTATTAATGTTAAAGGTTGCATACTCAATGGCGTAATGAAAAAATCTAGCTCGTATTATGGCTATGGGTATAATCATTATGGGTATACATATAATGATGATAAATAA	MSSTKSNKPLSADEIDIGRLYGELIDHRKLILSITAISVFISILYCLFATPIYQADALIQVEQKQGNTILESLSQVLPDAQPQSAPEISLLQSRMVLGKTVDDLKLQTIVTNNYFPIVGKGWARLFGDNPGNIYVENMVIPEKKLNENKKAIVTVINDSEYTVSIDDSTYHGKVGVQIKEPNISLLINKIDAQPGESFKIKYKTRLEAINDLANSFHVEDQGKDTGMLALTLIGDDPSLISVILNKISENYLEQNVSRQAAQDARSLEFLNERLPKVRDDLDRAEDKLNSYRKQKDSVDLSLEAKATLDQLVNVDNQINELTFREAEISQLFTKDHPTYKALIEKKNTLSKERGLLNNRISAMPATQQEVLRLSRDVESGRTVYMMLLNRQQELEISKSSAIGNVRIVDESVTEPEPVKPKKAMVIILGVLLGGLISVGVVLLRVSFRRGIESPEQLEEVGISVYSSIPVSEWLESNKKTRHGDSRNLLAIDNPADLAIEAIRGLRTSLHFAMLEAKNNILMISGASPNAGKTFVSSNLAVIEAQTGKSVLFIDADMRKGYSHKLFGINIGNDNVGLSELLSSNYDFEKAINKIAEMKIDFISRGQVPHNPAEMLTSMKFDNLLRWAASNYDLVIVDTPPVLAVTDAEIIGRYVGTTLLVARYETNTVKEMEVSIKRFERSGINVKGCILNGVMKKSSSYYGYGYNHYGYTYNDDK	MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVSAKVEPEARVLAMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDSEVFAESFATALAALHAVPISAAVDAGMLIRTPTQARQKVADDVDRVRREFVVNDKRLHRWQRWLDDDSSWPDFSVVVHGDLYVGHVLIDNTERVSGMIDWSEARVDDPAIDMAAHLMVFGEEGLAKLLLTYEAAGGRVWPRLAHHIAERLAFGAVTYALFALDSGNEEYLAAAKAQLAAAE	237.87	gnl|BL_ORD_ID|1139|hsp_num:0	1243			174	390	erythromycin; roxithromycin; telithromycin; clarithromycin; azithromycin; dirithromycin; oleandomycin
BGC0000732.1|Capsular_12 # 8408 # 9568 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.336	BGC0000732.1|Capsular_12 	8408	9568	+	Loose	700	62.3882	LpsB	26.49	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGTTTAAAATTCTTCGAGTCATTCCTTCAATGGATCCGCAAAAGGGAGGTCCATCTGAAGGTATCAGACAGCTTCAGCAAGAGATACATAGGCAACGATTAAATATAAAGTGCGATATAGTATGCATGGATGATTTATCAGAAGAAGCCAAAGATGTTGAGTATGCTAGTATTTATGCGGTGGGTAAAGGTAAAGGTGTATATTCATATTCAGAAAGCTTGAAAAATTGGCTAGAGGAAAATGTAAAAAAATATGATTTTGTAATAATTCATGGTATCTGGCAATATCATAGCTATATTGCTAGCAAATTATGTATTAAAAACAGCATCCCGTATTTTTTATATACTCATGGAATGCTTGACCCTTGGTTTAAAAAAAACTATCCATTAAAGCATATCAAAAAAATGCTTTATTGGACATTAATTGAGCGAAAAGTCGTGAACAATGCGGAGGCTGTTATATTTACAAGTGAAGAGGAAAAAATACTAGCACGTCAGTCATTCCCATTCTATGAACCAAAAGAATTTGTAACTGCATACGGAACTTCTGGTAGTATTTTCGATAAAGAGATTGCAAGGAGTGAATTTAATAAAAAATTCCCTTTTCTAAAAGGTAAAAAAATACTTCTTTATATGGGGCGAATTCATGAAAAAAAAGGATGTGATATATTAATAAAATCATATGCAAAAATCAGTAAAGAGCATAATGACTATCATTTGTTTATTGCTGGGCCGGATACGTCTGCATACGCAAAAACGTTGAAAGATCTTGTGTCCTCTTTAAATTTAAATGACAAAGTAACTTGGGGTGGAATGCTTAGTGGTGATGTAAAATGGGGCGCTTATTATTCAAGTGAGATTTTTTGCTTAGCATCACACCAAGAAAACTTTGGGATAGTTGTTGCAGAAGCCTTATCATGTGAGATTCCTGTTGTTACTACTACGAAAGTCAATATCTGGCGAGAAATAGAACGCGCTGATGCTGGCATGATTGCAATAGATAATGATGATTCTTTTACTGAAATACTAAATGAGTTTCTTAAAAAATACGAAAACGATCGTGAGAGATTAAGAGGGAATGCCTTGAGATGCTTTAAGGAAAACTTTGACATAAAACTTGTAGCGAAATCATTTAACAACTTAATATCCTCTGAACGATAA	MFKILRVIPSMDPQKGGPSEGIRQLQQEIHRQRLNIKCDIVCMDDLSEEAKDVEYASIYAVGKGKGVYSYSESLKNWLEENVKKYDFVIIHGIWQYHSYIASKLCIKNSIPYFLYTHGMLDPWFKKNYPLKHIKKMLYWTLIERKVVNNAEAVIFTSEEEKILARQSFPFYEPKEFVTAYGTSGSIFDKEIARSEFNKKFPFLKGKKILLYMGRIHEKKGCDILIKSYAKISKEHNDYHLFIAGPDTSAYAKTLKDLVSSLNLNDKVTWGGMLSGDVKWGAYYSSEIFCLASHQENFGIVVAEALSCEIPVVTTTKVNIWREIERADAGMIAIDNDDSFTEILNEFLKKYENDRERLRGNALRCFKENFDIKLVAKSFNNLISSER	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	105.46	gnl|BL_ORD_ID|2781|hsp_num:0	3793			489	1023	colistin A; colistin B; defensin
BGC0000732.1|Capsular_13 # 9596 # 10819 # 1 # ID=1_13;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.311	BGC0000732.1|Capsular_13 	9596	10819	+	Loose	500	29.261	AAC(3)-IIg	37.25	3005085	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	TTGAGATATCGAAGTTTTTTTAACTTAGTTTTCGGATTTCTTATTGGGCAAGGAGCAATGTTTATAGCGCAAACATTGTTAATTTCTAAATCTGAAGTTGCACTTGTTGGCCAAATTACAATTGGTCTAGGACTATTGACATTAGCTCAGTGGTTGGCTGATGCTGGAGGGGTGTTTTTAATACCGCGTTTGTTAGGCTCAGAAGAAAATCAACAAAAAAAATTAGCGTGCTTTATTAATGCGAGATTTATTTTTGTCACAATTATTGTTATAAGTGTTCTAGTTTATCTTATTGCTAAAAATTCGTGGCATCTATACTACGGACTCGTATCATTTATAATTCCTGTTTTGCTGATATCATCTTTTAGTGTACTTGGTTATCTCGATTTTTATAATGAAACGAAGGCTTCTGGAACATTGTCTGGAGTGTCTTGGTCATTAGCCTCATTGCCTTTGTATTATTCATATTTCTATGAAGGAGATAGATATATCATAGGTATGAGTGCTGGGCTGCTTTTTGTTTTAGGGAACGCATTATTTATAATAATTCAATGCATTAAAATGAAACAAGTAAGCAAGAATGGCGGGGTTAAATTGACATATAAGGATGGTTTTTGCATAAAACAGATAAAATATTCATTTTATGATATCATTAAATATAATTTGAACTATGGGTTTTCGCAAAGTTATGGAAGATTCGTCCCGATTTTCTTAAATACACTTTTAGGCCCTGTTCTGGCTGGGTATTACATATATGCTAAAAGTTTCGCAAACATTGCAAATCAATTTATAGCTTTCTCCAGAAGAGTTGAGTTTAGTAATCTGATCGCAATTCATGATGGAAGTGTTAGGAAAATATTATCCAGTCAGTTAATTAGCTTTGGCATTGCATGTATATTTGCGATATTTTGTTTTGGCGCTGAACTTGTAGAGTGTTTTTACACATTACCAATTGGAAATAATACTCTATTATATATACAAATTATAGCATTAATTAATCTGCTATGGTGTTTGTCAAGCTCATTTTCCCAGTATTTCATTGCGAAAGGGAAGTTGGGTTTTATCTGTATTACGCAATTAATTACTTATATTTTATCTTTGTCAATTATTTATTTTGGCGTTGATTATTTATCAATTTATTCAGTCTTTGTTGCTGAATCAATAATGTATGTTGTTCAATTCTTAATTTTTATAGTGTTTTTGAAAACTTATAAAAAGTTATAA	MRYRSFFNLVFGFLIGQGAMFIAQTLLISKSEVALVGQITIGLGLLTLAQWLADAGGVFLIPRLLGSEENQQKKLACFINARFIFVTIIVISVLVYLIAKNSWHLYYGLVSFIIPVLLISSFSVLGYLDFYNETKASGTLSGVSWSLASLPLYYSYFYEGDRYIIGMSAGLLFVLGNALFIIIQCIKMKQVSKNGGVKLTYKDGFCIKQIKYSFYDIIKYNLNYGFSQSYGRFVPIFLNTLLGPVLAGYYIYAKSFANIANQFIAFSRRVEFSNLIAIHDGSVRKILSSQLISFGIACIFAIFCFGAELVECFYTLPIGNNTLLYIQIIALINLLWCLSSSFSQYFIAKGKLGFICITQLITYILSLSIIYFGVDYLSIYSVFVAESIMYVVQFLIFIVFLKTYKKL	MNTRETIAADLSRLGVQSGALVMVHASLKAIGPVDGGAASIVSALLDAVGPTGSLMGYASWDRSPYEETLNGARMDAELRHRWPPFDPAISGTYRGFGLLNRFLLQTPGARRSAHPDASMVAVGPLAGTLTRPHELGQAFGPGSPLERFVERAGKVLLLGAPLDSVTVLHYAEAIARIPNKRRVSYEMPIRSEDGGVRWKRAEDFDSNGILDCFAIEGEPDAVETITNAYVELRRHREGLVGQAHCYLFEARDIVSFGVDYLQRHFGSP	151.30	gnl|BL_ORD_ID|2801|hsp_num:0	3820			510	648	dibekacin; sisomicin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; 2'-N-ethylnetilmicin; gentamicin
BGC0000732.1|Capsular_15 # 11976 # 12575 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.340	BGC0000732.1|Capsular_15 	11976	12575	+	Loose	400	58.5362	Pseudomonas aeruginosa catB6	27.97	3002678	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGAGTACAATTGTGATACCTAAAATGCAAAAAATTGATTATATAGCAAAGGAGGAAAATTTGTCTGGTGAATATGAAATTAACTACTTTAGCTTTAAAAATAAATTACATCGCTTAATTTGGGGGGGGGTGTATATAGTATTTTTTAAATATTCTCCTGTGCCCATGTTCGGATATAGGAATTTTATTCTTTCATTGTTTGGAGCTAGGCTTGGTAACAATGTCAGAATCTATCCAAGTGCTAAAATATGGATGCCAAGAAATTTAACCATTGGAAATAATTCCTCTATTGGGCCAAGGGCACTAATTTACAATCAGGGTTCTATTTATATCGGTAATGATTCAATTATTAGCCAAGATGTAACTATTTGTGCGAGTACGCATGATTACAACAAACGTGATCATCCCCTTATATTAAAGAATGTAGAAATTGGAAATAGAGTTTGGCTTTGTGCCGAGTCATTTGTTGGCCCTGGAGTTCAAGTTTTTGATGGGGCTGTGTTAGGTGCTAGAGCTGTCGCTAAGAGAAATTTATCTTCATGGTCTGTATACGATGGTAACCCATGTAATAAACTTAAAGAAAGAATGAATAATGAATAA	MSTIVIPKMQKIDYIAKEENLSGEYEINYFSFKNKLHRLIWGGVYIVFFKYSPVPMFGYRNFILSLFGARLGNNVRIYPSAKIWMPRNLTIGNNSSIGPRALIYNQGSIYIGNDSIISQDVTICASTHDYNKRDHPLILKNVEIGNRVWLCAESFVGPGVQVFDGAVLGARAVAKRNLSSWSVYDGNPCNKLKERMNNE	MENYFDSPFKGKLLSEQVTNRNIKVGRYSYYSGYYHGHSFDDCARYLLPDRDDVDKLIIGSFCSIGSGASFIMAGNQGHRHDWVTSFPFFYMQEEPAFSSSTDAFQKAGDTIVGNDVWIGSEAMIMPGIKIGDGAVIGSRSLVTRDVEPYTIIGGNPAKQIKKRFSDEEISLLMEMEWWNWPLDKIKTAMPLLCSSDIFGLHRHWRGIAV	94.76	gnl|BL_ORD_ID|1356|hsp_num:0	1316			168	504	azidamfenicol; chloramphenicol; thiamphenicol
BGC0000732.1|Capsular_17 # 13499 # 14617 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.420	BGC0000732.1|Capsular_17 	13499	14617	+	Loose	1200	43.5134	arnA	30.43	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAAAAAGGTTGCACTAATTACGGGCGTTACTGGTCAGGATGGTTCTTATCTTGCAGAGTTTTTACTCGAGAAAGGATATGAAGTTCATGGTATTAAACGGCGGTCTTCTTCATTTAACACAGATCGTGTTGATCATATTTATCAAGATCCTCACTCATCAAATCCGAAGTTCCATCTTCATTATGGCGATTTGACTGATACTTCTAACCTGACGAGACTTTTATCAGAAATAAAACCTGATGAGGTCTACAACTTGGGGGCTATGAGTCACGTTGCTGTTTCTTTCGAATCACCAGAATATACTGCTGATGTTGATGCTATTGGTACTCTTCGTCTACTAGAGGCTATTCGTTTTCTGGGGCTTGAGAAGAAAACCCGTTTCTATCAGGCATCTACTTCTGAACTATATGGTCTAGTGCAGGAAATTCCGCAAAAAGAGACAACTCCATTCTATCCTCGTTCACCATATGCAGTAGCGAAACTTTATGCATATTGGATTACGGTTAACTATCGTGAGTCATATGGAATGTACGCGTGCAATGGTATTCTGTTTAACCATGAATCACCACGCCGTGGCGAAACGTTTGTAACACGAAAAATTACACGTGGGCTTTCCAATATTGCTCAAGGTTTAGAAAAATGTCTTTATCTTGGTAATATGGACTCCTTACGAGACTGGGGGCATGCGAAAGACTATGTCAAAATGCAATGGTTAATGCTGCAACAAGAGCAACCGGAAGATTATGTTATTGCAACAGGCGTCCAATACTCGGTACGTCAATTCGTTGACTTTGCCGCATCCGAGTTGGGTATTAAATTACGCTTTGAGGGGCATGGCGTTGATGAAGTCGGAATTGTAGAGAGTGTTTCTGGTGAAGATGCACCTGCAGTTAACGTTGGTGACGTAATTGTGGCTGTTGATCCGCGGTATTTCCGTCCTGCTGAAGTGGAAACCTTACTTGGAGACCCTTCGAAAGCTCACGATAAATTGGGCTGGAAACCTGAAACAACCTTACAAGAGATGGTTGTCGAAATGGTTAGAAAGGATCTTGAGGCTGCTAAAAAGCATTCTCTACTCAAATCACATGGTTACGAGGTTTCGATTTCTCTGGAGTAA	MKKVALITGVTGQDGSYLAEFLLEKGYEVHGIKRRSSSFNTDRVDHIYQDPHSSNPKFHLHYGDLTDTSNLTRLLSEIKPDEVYNLGAMSHVAVSFESPEYTADVDAIGTLRLLEAIRFLGLEKKTRFYQASTSELYGLVQEIPQKETTPFYPRSPYAVAKLYAYWITVNYRESYGMYACNGILFNHESPRRGETFVTRKITRGLSNIAQGLEKCLYLGNMDSLRDWGHAKDYVKMQWLMLQQEQPEDYVIATGVQYSVRQFVDFAASELGIKLRFEGHGVDEVGIVESVSGEDAPAVNVGDVIVAVDPRYFRPAEVETLLGDPSKAHDKLGWKPETTLQEMVVEMVRKDLEAAKKHSLLKSHGYEVSISLE	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	56.19	gnl|BL_ORD_ID|1513|hsp_num:0	1643			960	1329	polymyxin B
BGC0000732.1|Capsular_18 # 14622 # 15590 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.383	BGC0000732.1|Capsular_18 	14622	15590	+	Loose	1900	36.5798	mexQ	26.21	3003699	protein homolog model	n/a	n/a	macrolide antibiotic; carbapenem; tetracycline antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACAATTAAGAAGAGAGTTTTTGTTGCTGGGCATAATGGTATGGTTGGGTCAGCAATCGTAAGACAATTGAAAAATAGAGACGACATTGAGCTCGTACTTCGTACACGTCAAGAGATCAACCTGCTTAATGCTCAAGACGTGAATGATTTTTTCGCTAATGAGCGTATTGATGAAGTATATTTAGCTGCTGCAAAAGTTGGCGGAATAGTTGCGAATAATACTTTTCCTGCTGATTTTATATATGAAAATATTCTTATTGAAGCTAATATTATACATGCTGCACATGTTAACGATGTCAATAAGATTATGTTTCTAGGTTCCTCATGTATTTATCCTAAATTTGCTAAGCAACCGATTAGTGAGTCCGAATTACTACAAGGAACACTTGAATCAACGAATGAACCGTATGCTATAGCAAAAATCGCTGGTATTAAACTCTGCGAGTCCTATAATCGACAACATAATCGAGATTATCGTTCAGTTATGCCAACTAACTTGTATGGAGAAAACGATAATTTCCACCCTTCTAATTCGCATGTAATTCCTGCATTACTACGCCGTTTTCATGAGGCAAAGTTAGAAGGTCTACCACAAGTTGTTGTATGGGGTAGTGGAACTCCGATGCGCGAGTTTCTGCATGTTGATGATATGGCTGCTGCATCTATTTATGTCATGGAGCTTGATAAAGCACTTTGGCAGGAGCAAACACAACCAATGCTTTCACATATTAACGTAGGCACTGGCGTTGATTGCTCTATTAAAGAGTTAGCCGAAACAATTTCAAAAGTTGTTGGTTATCAAGGGGAGGTCGTTTTTGATTCTACCAAACCTGACGGCACTCCTAGAAAGTTATTAGATGTTTCGAGATTAGAAGGTTTAGGCTGGAAGCATCAGGTTAATCTTGAAGCAGGCTTGGCACGGACTTATGAATGGTTTTTAAAAAATCAGAAAAGTTTCCGGAGTTAA	MTIKKRVFVAGHNGMVGSAIVRQLKNRDDIELVLRTRQEINLLNAQDVNDFFANERIDEVYLAAAKVGGIVANNTFPADFIYENILIEANIIHAAHVNDVNKIMFLGSSCIYPKFAKQPISESELLQGTLESTNEPYAIAKIAGIKLCESYNRQHNRDYRSVMPTNLYGENDNFHPSNSHVIPALLRRFHEAKLEGLPQVVVWGSGTPMREFLHVDDMAAASIYVMELDKALWQEQTQPMLSHINVGTGVDCSIKELAETISKVVGYQGEVVFDSTKPDGTPRKLLDVSRLEGLGWKHQVNLEAGLARTYEWFLKNQKSFRS	MTFPRFFIDRPIFAIVLSVLMMIGGIVSFFQLPLSEYPAVTPPTVQVTTAYPGANPDVIAQTVATPLEQAITGVEGMLYMSSQSATDGRMILTITFDQHIDPDMAQIQVQNRVSRVLSRLPDEVQRQGVVTQKTSPDILMVVHLLSPEQRYDPLYISNYAYLQVRDELLRLPGISDVVVWGAGEYSMRLWLDPDLIAARGLTAGEVIAAVREQNVQVAAGAVGQAPDSTAAFQVTVNTLGRLSDEEQFGDIIVRTGADGQVTRLRDVARIEMGGDAYALRSLLDGEPAVALQIIQSPGANALDTAEAVRATVARLEGNFPAGLSARIAYDPTVFVRASLQTVATTLLEAILLVVVVVVLFLRSWRASLIPLMAVPVSLVGTFAVMHLMGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHIENGEPPLQAARRAMDEVTGPIMAITSVLAAVFIPTAFLSGLQGEFYRQFALTIAISTILSALNSLTLSPALAGLLLRPRPAGGAVAGRFQRLLQVLGRPLRNAPEAYGNAVRKVVRVSGLALVVYGGLLGLTWVGFQAVPPGFVPMQDKYYLIGIAQLPNGASLERTDAVVRQMSRIGLDEPGVESVVAFPGLSVNGFVNVPNAAVMFFMLDPFESRTSADLGALAIAGRLQARFASIPDGFLGVFPPPPVPGLGTIGGFKMQVEDRGGAGLEALARQTQVLMMKATESGQLGGLMTSFDINAPQLEVVVDRTKVKSQGVRLADVFEALQVYLGSLYINDFNRFGRTYKVTAQADAPHRMQAEAIGRLQVRNAAGAMLPLSSFVTVTPSSGPDRVIHYNGYPSADISGGALPGVSSGQAVALMERLAGEVLPEGMTFEWTDLTYQQKLAGNSALFIFPLCVLLAYLILAAQYNSWLLPLAVLLIVPMCLLSAIAGVWLVGGDNNVFVQIGLVVLVGLAAKNAILIVEFARTLEAEGARALEAVVEACRLRLRPILMTSLAFIAGVVPLVMASGAGAEMRQAMGVAVFAGMLGVTLFGLFLTPVFYVLVRALAARLERRAGGSLAHLEGGRP	30.58	gnl|BL_ORD_ID|2010|hsp_num:0	2212			507	813	erythromycin; acriflavine; tetracycline; imipenem; trimethoprim; chloramphenicol; thiamphenicol; kitasamycin; rokitamycin
BGC0000732.1|Capsular_19 # 15592 # 16050 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.316	BGC0000732.1|Capsular_19 	15592	16050	+	Loose	590	23.8682	BES-1	39.13	3004751	protein homolog model	n/a	n/a	penam	antibiotic inactivation	BES Beta-lactamase	ATGTTTTTAGATGACAATGCATTTAAAAATATAATAAGAAATACACCACTTATTTCAATTGATTTAATCATTCAAAATGAGAAAGGTGAGTATTTAGTTGGTAAAAGAAACAACCGCCCCGCAAGGGGCTTTTGGTTTGTTCCTGGAGGGCGCATACTAAAAGATGAGTCATTGGATAATGGTTTTGCCAGACTGACCCAAAATGAAATTGGCATTAAAATGATACGAAATGAAAGCACTTTTCTTGGTATCTTTCAACATTTCTATGATGACAATTTTTTTAATAATGAATTTAGTACGCACTATATAGTATTGGCATATAAAACATCTATTATCTCCAGCGGTCTTGTATTTCCACATGAACAACATAATGAATACCACTGGATGGGTGTGGATGAAATACTTAATAATGATTTAGTACATTTTAATACTAAAGCTTATTTTATGGATGTTGCTTAG	MFLDDNAFKNIIRNTPLISIDLIIQNEKGEYLVGKRNNRPARGFWFVPGGRILKDESLDNGFARLTQNEIGIKMIRNESTFLGIFQHFYDDNFFNNEFSTHYIVLAYKTSIISSGLVFPHEQHNEYHWMGVDEILNNDLVHFNTKAYFMDVA	MWQWLGKVRWLLVVIALLGGKVMAASELDSALARLEQQHHGRLGLAYIDSGSGESYSYRGEERFAFCSTFKAVLAGAVLQRSVSQPGLLDKRVHYAATDLLAYAPITKTHLDKGMRIGELAAAAVQYSDNTAANLLLQEIGGVQALNRFVQGLGDPAFRLDRIEPHLNSAEPGDVRDTTTPLAMAHTLQAMTLGKGLPQAQQAQLVSWLKGNTTGAQRIQAGVPAGWQVGDKTGTGGYGTTNDIAILWPEQGAPKVLAIYFTQPAADAEANRAILAEATRLVLQDKSINKIK	52.05	gnl|BL_ORD_ID|2405|hsp_num:0	3560			54	123	
BGC0000732.1|Capsular_21 # 17580 # 18983 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.378	BGC0000732.1|Capsular_21 	17580	18983	+	Loose	1500	27.335	kdpD	23.24	3004047	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	kdpDE	ATGGCAACCTTGTATCATCGGACTCGCTCGAATGCGAATGCTTCTTTGATCTCAATGGCTCAACGCTTTTCCGATGTGGTCATAATATTTTTGGGATTATATTTGGTATGTCTTATTAACTCAGTCCCATTCGAATACCAACATGCCCTCATGTCTTTACTATCATTGGTCATTTTCCAGATGATAGGTGGTATAACTGATTTCTATCGCTCCTGGCGTGGCGTTGCGTTTTCTACAGAGTATATTTTAATTTTTAAAAACTGGACGCTTAGCTTATTAATTGCTTTAGGTCTTTTATCTTTAGACTCATCGATTGATACTCGTTTCTTACTTTTTATTCAGTGGTACTTGCTCGTTGATGTTGGTTTTTTTGTATGTCGCTCAGTTATCAGATTGATCTCTGGTTTACTTAGAAAATTTGGCTATAATACCAGAAGAGTGGCTGTTGTCGGCTCATTACCTGCAGGCATTAATTTGCTAAAAAGCTTTATTGAGCAGCCTTGGCTAGGCTTCGTTGTTAAAGGTATTTACGATAATATAAAATTGGATAGTGCCGAATATGACAATGTACCTTATGCTGGAAATATAGATAAACTTATTCAGGAGGCCCGTGAGGGTAAAATCGACCGTATTTATCTTGCGATGAGCATGCGCGATGAGTCCAAAATAAAGGATGTCGTTAGGAAATTAACAGATACAACTTGTTCTGTTTTGCTAATTCCTGATATTTTCACTTTTAACATCCTCCAGTCTCGTACAGAGGAAATTAATGGAGTGCCGGTTGTTCCTTTATTTGATTCACCGCTTAATGGCATTAATATGGTCTTTAAGCGTCTTGAAGATATAATTGTATCATCTTTGATTCTTATTCTGATATCACCAATTCTTCTGGTTATAGCTACTGCTGTTAAAACCACGTCGAAAGGGCCGGTTATTTTCCGCCAGGTGCGTTATGGAATGGACGGAAAACCTATAAAAGTTTGGAAATTTCGCTCGATGACTGTGATGGAAAACGACGATAAAGTTATTCAGGCTACAAAAAATGATATCCGCGTGACTAAAGTCGGCAAGTTTTTACGCAGCACTTCCTTAGACGAACTTCCGCAGTTCTTTAATGTACTTTTTGGTCAGATGTCCGTTGTAGGACCTCGACCACATGCAGTTTCTCATAACGAGCAATATCGGTCCTTAATTCAGGGGTATATGCTTCGTCATAAGGTTAAGCCAGGTATCACTGGCTTAGCACAAATTAATGGATGGCGTGGTGAAACGGATACTTTGGAAAAAATGGAAAAACGAATCGAATATGATTTGTTATATATCAGAGGTTGGAGCATTTGGTTAGATCTAAAAATAATATTCCTTACTGTCTTTAAAGGATTTATTAACAAATCTGCTTATTGA	MATLYHRTRSNANASLISMAQRFSDVVIIFLGLYLVCLINSVPFEYQHALMSLLSLVIFQMIGGITDFYRSWRGVAFSTEYILIFKNWTLSLLIALGLLSLDSSIDTRFLLFIQWYLLVDVGFFVCRSVIRLISGLLRKFGYNTRRVAVVGSLPAGINLLKSFIEQPWLGFVVKGIYDNIKLDSAEYDNVPYAGNIDKLIQEAREGKIDRIYLAMSMRDESKIKDVVRKLTDTTCSVLLIPDIFTFNILQSRTEEINGVPVVPLFDSPLNGINMVFKRLEDIIVSSLILILISPILLVIATAVKTTSKGPVIFRQVRYGMDGKPIKVWKFRSMTVMENDDKVIQATKNDIRVTKVGKFLRSTSLDELPQFFNVLFGQMSVVGPRPHAVSHNEQYRSLIQGYMLRHKVKPGITGLAQINGWRGETDTLEKMEKRIEYDLLYIRGWSIWLDLKIIFLTVFKGFINKSAY	MSNTESLNIGKKRGSLTIYIGYSPGVGKTFEMLSNAIELFQSNIDIKIGYIEPHQRDETNALAEQLPKIATNFTKHGSHHFQYLDVDRIIKESPTIVLIDELAHTNISRDRHEKRYMDIEEILNHGIDVHTTLNIQHIESLSSQIELMTGVHVKERVPDYFIMSADVLEVVDISPEQLIKRLKAGKVYKKDRLDVAFSNFFTYTHLSELRTLTLRTVADLMSDKEKVRHNHKTSLKPHIAVAISGSIYNEAVIKEAFHIAQKEHAKFTAIYIDVFEKNRQYKDSQKQVHQHLMLAKSLGAKVKVVYSQTVALGLDEWCKNQDVTKLIIGQHIRNKWRDFFNTPLIDHLMSFEHSYKIEIVPIKQIPVELKMNKSPYRPKGKRFAIDMLKMILIQIICVMMGLWIYQLDKHESSTIILMIFLIGIILLSIWTRSYIIGFLAAIINVFVFNYFFTEPRYTFEVYRFDYPITFIVSILTSILTSALLKQIKFQYSITKKQLYRTDLLFQFNDSIKQTYTVENLLINAGYQINQLLQQSITVYVINQSKVIKTIPLQNHIDNTTQQHEQALSWVIKNERQAGATTDTFPGINKWLIPIGTSPIKGILAIDYQSSQVINPYDASILESMLNELSLAVENVSLLKQTRESMLQAERQLTHSNFLRSISHDIRTPLTTIMGNLDILVSHSKDMSIIEKEQLLVHSFQESQYLYLLVTNILSLTKLQSSNVQIKLQPYLVSELVEEIDMILERRHLKKRITVSSSVDLQFIHIDSKLILQALFNLIENAVKHTSTDTKINLSIRYASDEQIEFAVIDEGPGISLEEQQKIFEPFYTGSNKYFKDNQKESMGLGLYLVQTILHKHQSNLQYKPNQPHGSIFYFNIDTDFNEGDI	52.77	gnl|BL_ORD_ID|4924|hsp_num:0	5918			2019	2406	kanamycin A
BGC0000732.1|Capsular_22 # 19147 # 20553 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.508	BGC0000732.1|Capsular_22 	19147	20553	+	Loose	500	28.4906	mphJ	28.57	3004544	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGTCCAAGCAACAGATCGGGGTTGTCGGTATGGCTGTGATGGGGCGTAACCTTGCGCTGAATATCGAAAGCCGTGGTTATACCGTCTCCGTTTTCAACCGCTCCCGTGAAAAGACCGAAGAAGTGATTGCCGAAAACCCAGGCAAGAAACTGGTTCCTTACTACACAGTACAAGAGTTTGTTGAATCCCTCGAAACACCACGTCGTATCCTGTTGATGGTGAAGGCCGGGGCTGGCACCGACAGCGCCATCGATTCCCTGAAGCCTTACCTCGACAAAGGCGACATCATCATTGATGGCGGCAATACCTTCTTCCAGGACACCATCCGTCGTAACCGTGAACTGTCTGCCGAAGGTTTTAACTTTATCGGTACCGGTGTTTCCGGTGGAGAAGAGGGGGCTCTGAAAGGGCCTTCCATCATGCCCGGTGGCCAGAAAGAAGCCTATGAGCTGGTTGCTCCAATTCTGAAGCAGATTGCTGCGGTTGCTGAAGACGGCGAGCCATGTGTCACCTATATCGGTGCTGATGGTGCTGGTCATTATGTGAAGATGGTTCATAACGGCATCGAGTATGGCGATATGCAACTCATTGCAGAAGCTTATGCGCTGTTGAAAGGCGGTCTGGCTCTTTCCAACGAAGAGCTGGCGCAAACCTTCACCGAATGGAACGAAGGTGAACTGAGCAGTTACCTGATCGACATTACCAAAGATATCTTCACCAAGAAGGATGAAGAAGGTAAGTACCTCGTTGATGTCATTCTTGATGAAGCTGCAAACAAAGGTACCGGTAAGTGGACCAGCCAGAGCTCACTTGATCTCGGCGAACCTCTGTCTCTGATCACCGAGTCCGTATTTGCTCGTTACATCTCTTCGCTTAAAGACCAGCGTGTAGCTGCTTCGAAAGTGCTGAGTGGTCCGCAGGCTCAACCGGCCGGTGATAAAGCGGAATTTATCGAAAAAGTTCGTCGCGCGTTGTACCTCGGTAAAATCGTCTCCTATGCTCAGGGTTTCTCCCAGCTGCGTGCTGCTTCCGATGAATATAACTGGGATCTGAACTACGGCGAGATCGCTAAGATTTTCCGCGCTGGCTGCATAATTCGTGCGCAGTTCCTGCAGAAGATCACCGATGCTTATGCGCAAAAGGCTGGTATTGCTAACCTCCTGCTGGCGCCGTACTTCAAACAGATCGCTGATGACTATCAGCAGGCGCTGCGTGATGTCGTGGCGTATGCCGTACAGAATGGTATTCCGGTACCGACTTTCTCTGCGGCAATTGCCTACTATGACAGCTACCGTTCCGCAGTTCTGCCCGCTAACCTGATTCAAGCTCAGCGTGATTACTTTGGTGCGCACACTTATAAGCGTACTGATAAAGAAGGTGTATTCCATACCGAGTGGTTGGAATAA	MSKQQIGVVGMAVMGRNLALNIESRGYTVSVFNRSREKTEEVIAENPGKKLVPYYTVQEFVESLETPRRILLMVKAGAGTDSAIDSLKPYLDKGDIIIDGGNTFFQDTIRRNRELSAEGFNFIGTGVSGGEEGALKGPSIMPGGQKEAYELVAPILKQIAAVAEDGEPCVTYIGADGAGHYVKMVHNGIEYGDMQLIAEAYALLKGGLALSNEELAQTFTEWNEGELSSYLIDITKDIFTKKDEEGKYLVDVILDEAANKGTGKWTSQSSLDLGEPLSLITESVFARYISSLKDQRVAASKVLSGPQAQPAGDKAEFIEKVRRALYLGKIVSYAQGFSQLRAASDEYNWDLNYGEIAKIFRAGCIIRAQFLQKITDAYAQKAGIANLLLAPYFKQIADDYQQALRDVVAYAVQNGIPVPTFSAAIAYYDSYRSAVLPANLIQAQRDYFGAHTYKRTDKEGVFHTEWLE	MSKNNVEHMLALAKNNGILVDPTTVKVNESGLDFLAIFASTIDGIPWVLRQPRRDDVVETARYEKRVLDLVAKHLRVEVPDWQVHTSEFIAYPILGGTPMATINMETKNYDWYLNPESLPELCIQTWAEALVELHGIHHDLARDAGIRVKQPSYARASLREKMNEIKRVFGVSGALWDRWQKWLADETFWPAHSALVHGDLHPGHILVAENGKVTGLLDWTEAEVSDPAIDFTVVYLLFGDTGLADFIQRYEKAGGRVWSRMHEHIVEMTAAYPVTLATFALKSGLEEFKIMARQALGVDENGKEITS	151.95	gnl|BL_ORD_ID|2691|hsp_num:0	3220			207	375	erythromycin; telithromycin; tylosin
